India and the Netherlands are joining forces in the new joint accelation WAH! Accelerator. Several AMR-global partners are involved. On behalf of the NADP, Cornelis Boersma and Simon van der Pol will travel to India.
The WHO has released a report on fungal pathogens. It is the first global effort to systematically prioritize fungal pathogens, taking into account their unmet research and development needs, and perceived public health importance.
This 18 November, Antimicrobioal Resistance Multi-Stakeholder Partnership Platform will be launched. The Platform aims to create a global movement for change on AMR, raise awareness of the role everyone should play in tackling AMR, and highlight the importance of a collaborative One Health approach in addressing AMR issues.
AMR-Global organises its 8th Annual Partnership Meeting on November 2.
The GARDP (Global Antibiotic Research & Development Partnerships) has three upcoming webinars. The organization has organized these live seminars to discusscurrent challenges in antibiotic research.
The World Health Organization has released a report on antimicrobial-resistant (AMR) bacterial pathogens. The analysis points to the need of accelerating vaccine development and maximizing current vaccines related to AMR.